| Application no. and date | 20717363.4 (espacenet) (Federated) (European Patent Register), 20200304 | | Patent/reg. no. and date | DK/EP 3935068, 20230906 | | Publication date | 20220112 | | Priority no. and date | US 201962814568 P, 20190306, US 201962849259 P, 20190517 | | EP pub. no. and date |
EP 3935068 20220112 | | Effective date | | | Applicant/owner | Astellas US LLC, 2375 Waterview Drive
Northbrook IL 60062, US | | Applicant ref. no. | PM360743DKQ | | Inventor | SHARP, Matthew, J., c/o Propella Therapeutics, Inc. 480 Hillsboro
Street, Suite 130A
Pittsboro, NC 27312, US,
MOORE, William, R., c/o Propella Therapeutics, Inc. 480 Hillsboro
Street, Suite 130A
Pittsboro, NC 27312, US | | Representative | Marks & Clerk LLP, 44 rue de la Vallée
BP 1775
L-1017 Luxembourg, LU | | Opponent | | | IPC Class | A61K 31/58 (2006.01) , A61P 35/00 (2006.01) , A61P 5/28 (2006.01) , A61P 5/46 (2006.01) , C07J 43/00 (2006.01) | | Title | ABIRATERON-PRODRUGS | | Int. application no. | US2020020915 | | Int. publication no. | WO2020180942 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
